You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 864 AVA-NP-695, a potent and selective ENPP1 inhibitor, demonstrates strong anti-tumor efficacy as monotherapy and in combination with radiation

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
864 AVA-NP-695, a potent and selective ENPP1 inhibitor, demonstrates strong anti-tumor efficacy as monotherapy and in combination with radiation

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023154013
Dec 20233006
Jan 20243303
Feb 20241600
Mar 20242603
Apr 20243004
May 20244205
Jun 20243604
Jul 20249404
Aug 20241402
Sep 20242402
Oct 20242005
Nov 202466015
Dec 20244808
Jan 20253609
Feb 20252003
Mar 2025006
Apr 2025008
May 20250012
Jun 2025003
Total6890115